Rapid, Simple, and Sensitive Spectrofluorimetric Method for the Estimation of Ganciclovir in Bulk and Pharmaceutical Formulations

被引:6
作者
Balwani, Garima [1 ]
Joseph, Emil [1 ]
Reddi, Satish [1 ]
Nagpal, Vibhu [1 ]
Saha, Ranendra N. [1 ]
机构
[1] BITS Pilani, Dept Pharm, Pilani 333031, Rajasthan, India
关键词
PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; ACYCLOVIR;
D O I
10.1155/2013/972806
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A new, simple, rapid, sensitive, accurate, and affordable spectrofluorimetric method was developed and validated for the estimation of ganciclovir in bulk as well as in marketed formulations. The method was based on measuring the native fluorescence of ganciclovir in 0.2 M hydrochloric acid buffer of pH 1.2 at 374 nm after excitation at 257 nm. The calibration graph was found to be rectilinear in the concentration range of 0.25-2.00 mu g mL(-1). The limit of quantification and limit of detection were found to be 0.029 mu g mL(-1) and 0.010 mu g mL(-1), respectively. The method was fully validated for various parameters according to ICH guidelines. The results demonstrated that the procedure is accurate, precise, and reproducible (relative standard deviation <2%) and can be successfully applied for the determination of ganciclovir in its commercial capsules with average percentage recovery of 101.31 +/- 0.90.
引用
收藏
页数:5
相关论文
共 15 条
[1]  
[Anonymous], 2005, INT C HARM ICH VAL A
[2]   Determination of ganciclovir in different matrices from solid organ transplanted patients treated with a wide range of concomitant drugs [J].
Asberg, Anders ;
Hansen, Christin Nupen ;
Reubsaet, Leon .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (03) :1039-1044
[3]   Development and validation of a sensitive method for the determination of ganciclovir in human plasma samples by reversed-phase high-performance liquid chromatography [J].
Campanero, MA ;
Sadaba, B ;
García-Quetglas, E ;
Azanza, JR .
JOURNAL OF CHROMATOGRAPHY B, 1998, 706 (02) :311-317
[4]   A rapid, sensitive HPLC method for the determination of ganciclovir in human plasma and serum [J].
Chu, F ;
Kiang, CH ;
Sung, ML ;
Huang, B ;
Reeve, RL ;
Tarnowski, T .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (03) :657-667
[5]   Investigation of CMV disease in immunocompromised patients [J].
Emery, VC .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (02) :84-88
[6]  
Espinosa Bosch M., 2009, Asian Journel of pharmaceutical Science, V4, P254
[7]   GANCICLOVIR - A REVIEW OF ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN CYTOMEGALOVIRUS INFECTIONS [J].
FAULDS, D ;
HEEL, RC .
DRUGS, 1990, 39 (04) :597-638
[8]   Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome [J].
Jacobson, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) :105-114
[9]   Development of a sensitive method for the determination of ganciclovir by reversed-phase high-performance liquid chromatography [J].
Merodio, M ;
Campanero, MA ;
Mirshahi, T ;
Mirshahi, M ;
Irache, JM .
JOURNAL OF CHROMATOGRAPHY A, 2000, 870 (1-2) :159-167
[10]   Determination of ganciclovir in human plasma by ultra performance liquid chromatography-UV detection [J].
Padulles, A. ;
Colom, H. ;
Armendariz, Y. ;
Cerezo, G. ;
Caldes, A. ;
Pou, L. ;
Torras, J. ;
Grinyo, J. M. ;
Lloberas, N. .
CLINICAL BIOCHEMISTRY, 2012, 45 (4-5) :309-314